- Mazumdar, Abhijit;
- Tahaney, William M;
- Hill, Jamal L;
- Zhang, Yun;
- Ramachandran, Sumankalai;
- Kawedia, Jitesh;
- Qian, Jing;
- Contreras, Alejandro;
- Savage, Michelle I;
- Vornik, Lana A;
- Sei, Shizuko;
- Mohammed, Altaf;
- Brown, Powel H
Our results show that everolimus delays mammary tumor formation in multiple mouse models, suggesting that mTOR inhibitors will be useful for the prevention of ER-negative and triple-negative breast cancer in humans. See related Spotlight, p. 787.
